Let's Fight Together Against Blindness! With Al-Shifa Trust
×

Al-Shifa Research Center

 

Vision:

To be the centre of excellence for conducting world-class and creative bio-medical research activities to enhance the knowledge base and contribute towards improving the health care system and social advancement for the people of Pakistan.

Mission:

To be the centre of excellence for conducting world-class and creative bio-medical research activities to enhance the knowledge base and contribute towards improving the health care system and social advancement for the people of Pakistan.

Aim and Objectives

To be the centre of excellence for conducting world-class and creative bio-medical research activities to enhance the knowledge base and contribute towards improving the health care system and social advancement for the people of Pakistan.

  • Work in coordination with the head of departments to identify areas of research
  • Provide operational support to the institution’s research activities/program and play a central role in facilitating the research outcome
  • Enhance the capacity building of trainees and students in academic research
  • Facilitating the faculty/postgraduate students to apply for research grants to HEC and other donor agencies
  • Find and explore the collaborations with national and international organizations
  • Establish and implement appropriate procedures and guidelines for monitoring research progress

Establishing a research centre shows that we really see value in bringing scientific evidence and also appreciate the importance of scientific culture. We believe that as long as we continue to work together as a team, we can give the very best of ourselves. We are dedicated to driving impact in critical spheres of health care to create impressive and meaningful breakthroughs and to fostering innovation through partnerships and team works. Al-Shifa Research Centre also prepares an annual research report covering the diverse array of all research activities done by the faculty, students, and trainees of Al-Shifa.

Prof. Dr. Ume Sughra
MBBS, MPH, FCPS (Comm. Med),
FRCP (Glasgow), MCPS-HPE
Director Research, Al-Shifa Research Centre
Professor of Public Health
E-mail: dr_sughra@yahoo.com


Clinical Trials

Trial Name Sponsor CRO Status
A Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO cell) for Prevention of COVID-19 Anhui Zhifei Longcom Biopharmaceutical Co., Ltd China DRK Pharma Solutions Lahore On going
Published in The New England Journal of Medicine
DOI: 10.1056/NEJMoa2202261

Collaborators

Clinical Trial Team - ZF2001

Prof. Dr. Ume Sughra

Principal Investigator

Dr. Marriam Suleman

Trial Manager
Co-Principal Investigator

Dr. Asmaa Riaz

Trial Manager
Co-Principal Investigator

Dr. Rasikh Arif

Co-Principal Investigator

Dr. Fatima Farahi

Research Officer

Dr. Amna Shahid

Research Officer

Dr. Ali Zeb Khan

Research Officer

Projects

Sr. no. Project Name Sponsor Principal Investigator Status
1. A Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO cell) for Prevention of COVID-19 Anhui Zhifei Longcom Biopharmaceutical Co., Ltd China Prof. Dr. Ume Sughra On going
Published in The New England Journal of Medicine
DOI: 10.1056/NEJMoa2202261
2. A project by WHO to evaluate the preparedness of public health facilities in Islamabad Capital Territory and Rawalpindi, Pakistan, for managing (potential) CBRN events and development of a standard national tool to evaluate hospital preparedness involving Emergency Departments (ED) as well as EMS providers’ readiness for CBRN events in Pakistan WHO EMRO, Pakistan Prof. Dr. Ume Sughra Completed

Annual Research Reports

2018

2019

2020

2021

Events

1st Al-Shifa International Research Conference 2021

An international conference on COVID 19 Phase III Clinical Trials in Pakistan was held at Al Shifa Trust Rawalpindi on Wednesday, December 8th, 2021. It was the first international research conference by Al Shifa Trust. The theme for the research was building research expertise with changing times, research at the forefront of Pandemic. Esteemed decision-makers, researchers, academia faculty and scholars, renowned researchers, and representatives from World Health Organization and Drug Regulatory Authority Pakistan took part in the conference.

The conference was put together to highlight the research opportunities generated as a result of the pandemic in Pakistan and the role of national institutes in becoming a part of global activities to combat the pandemic through research in Pakistan. The paradigm shift from curative to preventive medicine was also discussed by the national and international speakers present at the conference.

We are looking for donors who believe in eye health and a brighter world. Make a donation today, and help us continue the good cause of fighting blindness in Pakistan.

 

Maj Gen (Retd) Rehmat Khan

President
Al-Shifa Trust Eye Hospital

Prof. Dr. Wajid Ali Khan

Dean and Chief of Medical Services
Head of Cornea Department
Al-Shifa Trust Eye Hospital

Welcome Address and introduction of Al-Shifa Trust Eye Hospital and Establishment of Research Centre

Prof. Dr. Ume Sughra

Principal Investigator of ZF2001 Phase III Clinical Trial
Director Research

Al-Shifa Trust Eye Hospital
Topic: COVID-19 Phase III Clinical Trial at Al-Shifa Clinical Trial Site

Dr. Shahzad Ali Khan

Vice Chancellor
Health Services Academy Islamabad

Topic: Public Health Response In COVID-19

Dr. Palitha Mahipala

WHO Representative
Pakistan

Topic: WHO support to Government of Pakistan for COVID-19 Response

Major General Dr. Aamer Ikram, SI(M)

Executive Director
NIH Pakistan

Topic: Role of NIH in COVID-19 Response in Pakistan

Prof. Dr. Javed Akram

Vice Chancellor
University of Health Sciences Lahore
President
Pakistan Society of Internal Medicine

Topic: Institutional Experience Of COVID-19 Phase III Trials University Of Health Sciences, Lahore

Ms Maria Song

Chinese Representative

Topic: Anhui Zhifei Longcom Biopharmaceutical Co., Ltd Recombinant COVID-19 Vaccine (CHO Cell), Zifivax®, ZF2001

Dr. Abdur Rashid

Ex-Chairman, Clinical Studies Committee & Ex-Director, Pharmacy Services, Drug Regulatory Authority of Pakistan Ex-President, Pharmacy Council of Pakistan

Topic: The Country Situation In Clinical Trials, A Drap Perspective

Dr. Jawad Gill

Head Of Clinical Operations
DRK Pharma Solutions Lahore

Topic: Role Of DRK In Bringing & Conducting Clinical Research To Pakistan

Dr. Zahid A. Butt

Assistant Professor
School Of Public Health Sciences
University of Waterloo Ontario Canada

Topic: Infodemiology and Infoveillance: An overview

 

08-12-2021

Al-Shifa Research Centre

Contact Us

Al-Shifa Research Centre,
Pakistan Institute Of Ophthalmology (PIO),
Al-Shifa Trust Eye Hospital,
Jhelum Road, Rawalpindi, Pakistan.

Phone: 051-5487821-5 Ext 372
Email: dr_sughra@yahoo.com

Make a Donation

Rs.

Feedback us